Literature DB >> 11092766

Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.

M R Hoehe1, K Köpke, B Wendel, K Rohde, C Flachmeier, K K Kidd, W H Berrettini, G M Church.   

Abstract

To analyze candidate genes and establish complex genotype-phenotype relationships against a background of high natural genome sequence variability, we have developed approaches to (i) compare candidate gene sequence information in multiple individuals; (ii) predict haplotypes from numerous variants; and (iii) classify haplotypes and identify specific sequence variants, or combinations of variants (pattern), associated with the phenotype. Using the human mu opioid receptor gene (OPRM1) as a model system, we have combined these approaches to test a potential role of OPRM1 in substance (heroin/cocaine) dependence. All known functionally relevant regions of this prime candidate gene were analyzed by multiplex sequence comparison in 250 cases and controls; 43 variants were identified and 52 different haplotypes predicted in the subgroup of 172 African-Americans. These haplotypes were classified by similarity clustering into two functionally related categories, one of which was significantly more frequent in substance-dependent individuals. Common to this category was a characteristic pattern of sequence variants [-1793T-->A, -1699Tins, -1320A-->G, -111C-->T, +17C-->T (A6V)], which was associated with substance dependence. This study provides an example of approaches that have been successfully applied to the establishment of complex genotype-phenotype relationships in the presence of abundant DNA sequence variation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092766     DOI: 10.1093/hmg/9.19.2895

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  76 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups.

Authors:  Corinna Herrnstadt; Joanna L Elson; Eoin Fahy; Gwen Preston; Douglass M Turnbull; Christen Anderson; Soumitra S Ghosh; Jerrold M Olefsky; M Flint Beal; Robert E Davis; Neil Howell
Journal:  Am J Hum Genet       Date:  2002-04-05       Impact factor: 11.025

3.  Clone-based systematic haplotyping (CSH): a procedure for physical haplotyping of whole genomes.

Authors:  Carola Burgtorf; Pamela Kepper; Margret Hoehe; Carsten Schmitt; Richard Reinhardt; Hans Lehrach; Sascha Sauer
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

4.  Digital genotyping and haplotyping with polymerase colonies.

Authors:  Robi D Mitra; Vincent L Butty; Jay Shendure; Benjamin R Williams; David E Housman; George M Church
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

5.  MALDI mass spectrometry analysis of single nucleotide polymorphisms by photocleavage and charge-tagging.

Authors:  Sascha Sauer; Hans Lehrach; Richard Reinhardt
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

6.  A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women.

Authors:  Howard A Crystal; Sara Hamon; Matthew Randesi; Judith Cook; Kathryn Anastos; Jason Lazar; Chenglong Liu; Leigh Pearce; Elizabeth Golub; Victor Valcour; Kathleen M Weber; Susan Holman; Ann Ho; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2010-11-11       Impact factor: 4.280

7.  [Are polymorphisms in the mu-opioid receptor important for opioid therapy?].

Authors:  J Lötsch; R Freynhagen; G Geisslinger
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 8.  [Genetics, pain and analgesia].

Authors:  U Stamer; B Bayerer; F Stüber
Journal:  Anaesthesist       Date:  2006-07       Impact factor: 1.041

9.  Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants.

Authors:  Lili Xin; Zaijie Jim Wang
Journal:  AAPS PharmSci       Date:  2002

10.  Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Authors:  Toni-Kim Clarke; Richard C Crist; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'Brien; David W Oslin; Thomas N Ferraro; Falk W Lohoff; Wade H Berrettini
Journal:  Neurosci Lett       Date:  2013-02-20       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.